Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-061382
Filing Date
2012-11-13
Accepted
2012-11-13 13:04:30
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v326067_10q.htm 10-Q 484809
2 EXHIBIT 31.1 v326067_ex31-1.htm EX-31.1 8178
3 EXHIBIT 31.2 v326067_ex31-2.htm EX-31.2 8131
4 EXHIBIT 32.1 v326067_ex32-1.htm EX-32.1 5122
  Complete submission text file 0001144204-12-061382.txt   3137810

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ecyt-20120930.xml EX-101.INS 394424
6 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20120930.xsd EX-101.SCH 23170
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20120930_cal.xml EX-101.CAL 28946
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20120930_def.xml EX-101.DEF 133094
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20120930_lab.xml EX-101.LAB 227221
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20120930_pre.xml EX-101.PRE 172225
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 121197556
SIC: 2834 Pharmaceutical Preparations